Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Fatigue 12cyclopia sequence 2Sleep Initiation and Maintenance Disorders 2Neoplasms 2Glioma 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Brain Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Sleepiness 1Prostatic Neoplasms 1Parasomnias 1Pain 1Oligodendroglioma 1Neurotoxicity Syndromes 1Nervous System Neoplasms 1Multiple Myeloma 1Meningioma 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma, Subependymal 1Glioblastoma 1Esophageal Neoplasms 1Ependymoma 1Cognition Disorders 1Cancer Related Fatigue 1Astrocytoma 1

Interventions

Dexamethasone 362Bortezomib 231Lenalidomide 200Cyclophosphamide 174Melphalan 154Calcium Dobesilate 107Peripheral Blood Stem Cell Transplantation 92fludarabine phosphate 84Thalidomide 81Filgrastim 71carfilzomib 68pomalidomide 66Granulocyte Colony-Stimulating Factor 60Mycophenolic Acid 59Busulfan 57daratumumab 54Whole-Body Irradiation 54Tacrolimus 51ixazomib 50Prednisone 50Cyclosporine 49fludarabine 46Antilymphocyte Serum 35Etoposide 30dexamethasone acetate 29Methotrexate 29plerixafor 27Radiotherapy 26Doxorubicin 26dexamethasone 21-phosphate 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Multiple Myeloma × Modafinil × Clear all
NCT01160380 2014-11-06

A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma

Oncotherapeutics

Phase 3 Completed
50 enrolled 14 charts
Plasma cell

Fatigue, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡